Kerala Ayurveda Ltd
16 Nov 2026 12:00 AM
Kerala Ayurveda Ltd consolidated sales up 7.71% on year in Q2FY2027,
Kerala Ayurveda Ltd`s net loss stood at Rs 6.1 crore in Q2FY2027 compared to a net loss of Rs 6.36 crore in Q2FY26. The revenue from operations improved marginally 7.71% to Rs 35.75 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.76 lakh crore, rising 6.98%. It has eased by 0.66% over last one week and ticked higher by 6.26% in last one month while the market capitalization of Kerala Ayurveda Ltd has softened by 9.88% and 17.84% in the same period respectively.
Profit before tax (PBT) of Kerala Ayurveda Ltd stood at Rs 6.37 crore in Q2 FY27, slipping 6.60% year-on-year, and tumbling by 22.60% quarter-on-quarter. EBITDA came in at Rs 3 crore, plunging by 47.52% YoY and retreating 14.67% sequentially.
Total expenses inched up 2.55% to Rs 39.88 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 5.94 crore, contracting by 19.18% YoY, while employee benefits expense was at Rs 17.87 crore, softening 5.15% YoY.
For FY26, revenue from operations improved 16.66% to Rs 120.33 crore, while net profit surged by 2392.86% to Rs 13.96 crore, compared to previous FY. EBITDA witnessed a strong improvement of 1007% to Rs 6.81 crore, and PBT collapsed by 1954.55% to Rs 12.24 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 4.83 crore in FY26, as against Rs 0.96 crore in FY25.
Kerala Ayurveda Ltd crashed 62.26% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.42% during the same period.
Kerala Ayurveda Ltd
13 Nov 2026 12:00 AM
Kerala Ayurveda Ltd consolidated sales up 7.71% on year in Q2FY2027,
Kerala Ayurveda Ltd share price tumbled by 9.38% to Rs 152.1 after the company`s net profit witnessed a sharp fall of 24.50% to Rs 6.1 crore, while revenue from operations improved marginally 7.71% to Rs 35.75 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, easing 6.40%. It has inched up 2.89% over last one week and ticked higher by 6.37% in last one month while the market capitalization of Kerala Ayurveda Ltd has improved by 6.14% and 0.52% in the same period respectively.
Profit before tax (PBT) of Kerala Ayurveda Ltd stood at Rs 6.37 crore in Q2 FY27, declining 6.60% year-on-year, and tumbling by 22.60% quarter-on-quarter. EBITDA came in at Rs 3 crore, plunging by 47.52% YoY and retreating 14.67% sequentially.
Total expenses grew marginally by 2.55% to Rs 39.88 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 5.94 crore, contracting by 19.18% YoY, while employee benefits expense was at Rs 17.87 crore, softening 5.15% YoY.
For FY26, revenue from operations grew 16.66% to Rs 120.33 crore, while net profit jumped 2392.86% to Rs 13.96 crore, compared to previous FY. EBITDA jumped by 1007% to Rs 6.81 crore, and PBT plunged by 1954.55% to Rs 12.24 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 4.83 crore in FY26, as against Rs 0.96 crore in FY25.
Kerala Ayurveda Ltd crashed 61.58% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.03% during the same period.
Kerala Ayurveda Ltd
12 Nov 2026 12:00 AM
Kerala Ayurveda Ltd consolidated sales down 4.46% on year in Q1FY2027, net profit saw a marginal increase of 9.19%,
Kerala Ayurveda Ltd share price inched up 2.75% to Rs 167.85 after the company`s net profit saw a mild growth of 9.19% to Rs 8.08 crore, while revenue from operations eased by 4.46% to Rs 33.19 crore in Q1FY27 over Q1FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, easing 5.84%. It has improved by 3.49% over last one week and ticked higher by 6.26% in last one month while the market capitalization of Kerala Ayurveda Ltd has increased 13.61% and 9.78% in the same period respectively.
Profit before tax (PBT) of Kerala Ayurveda Ltd stood at Rs 8.23 crore in Q1 FY27, tumbling by 392.88% year-on-year, and rising 3.13% quarter-on-quarter. EBITDA came in at Rs 4 crore, plunging by 70.06% YoY and crashing by 54.61% sequentially.
Total expenses reduced by 10.66% to Rs 38.89 crore in Q1FY27 over Q1FY26. During the quarter, cost of materials consumed stood at Rs 7.35 crore, growing marginally by 0.27% YoY, while employee benefits expense was at Rs 18.84 crore, slipping by 3.58% YoY.
For FY26, revenue from operations advanced 16.66% to Rs 120.33 crore, while net profit surged by 2392.86% to Rs 13.96 crore, compared to previous FY. EBITDA soared by 1007% to Rs 6.81 crore, and PBT tumbled by 1954.55% to Rs 12.24 crore compared to previous FY.
The company`s consolidated net cash flow from operating activities stood at Rs 4.83 crore in FY26, as against Rs 0.96 crore in FY25.
Kerala Ayurveda Ltd crashed 56.04% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.37% during the same period.
Kerala Ayurveda Ltd
05 Nov 2026 12:00 AM
Kerala Ayurveda to review quarterly, half-year financials at board meeting November 12,
Kerala Ayurveda Limited will hold a board meeting on Thursday, November 12, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, according to a regulatory filing with the Bombay Stock Exchange. The trading window for the company`s securities has been closed for designated persons since September 30, 2026, and will reopen 48 hours after the announcement of the financial results.
Kerala Ayurveda Ltd
21 Oct 2026 12:00 AM
Kerala Ayurveda allotted shares to Katra Holding, partially settling a Rs 12.47 crore loan,
Kerala Ayurveda Limited announced the allotment of 6,55,000 equity shares at a price of Rs 190.37 per share to Katra Holding Private Limited, a promoter group entity, partially adjusting an existing unsecured loan of Rs 12,46,92,350. The allotment increases the company’s paid-up equity share capital from Rs 12,99,50,850 divided into 1,29,95,085 shares to Rs 13,65,00,850 divided into 1,36,50,085 shares, and the shares will be listed on the Bombay Stock Exchange.
Subscribe for our
newsletter
newsletter
HSL Mobile App